Revised Investor Presentation for Unaudited Consolidated Financial Results of the Company for the quarter ended June 30 2026
21-Jul-2026
Download PDF
Anthem Biosciences
Revised Investor Presentation for Unaudited Consolidated Financial Results of the Company for the quarter ended June 30 2026